APOC3 and atherosclerosis: These knockout models show a favorable cardiovascular profile, marked by fewer arterial plaques and reduced atherosclerosis risk—findings that parallel human studies showing that loss-of-function APOC3 mutations are associated with lower TG levels and reduced cardiovascular risk [120,122].